| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KATMR
|
1.86 | 4.0B | 5.42 | 0.40 | 5.37 | 4.2% | 31.4% | 70 | 23 | 4.44 | +100.0% | 65 | 0.22 |
|
BRISA
|
74.05 | 22.6B | — | 0.87 | 3.28 | 2.9% | 27.7% | 65 | 44 | 186.45 | +97.2% | 57 | 0.59 |
|
EGEEN
|
4,810.00 | 15.2B | 21.76 | 3.76 | 13.43 | 20.7% | 40.6% | 58 | 28 | 4,402.61 | -6.1% | 94 | 0.38 |
|
PARSN
|
68.95 | 5.3B | — | 0.50 | 3,069.82 | -2.1% | 25.1% | 47 | 20 | 112.04 | +31.9% | 20 | 0.44 |
|
GOODY
|
2.62 | 4.0B | — | 1.71 | 5.88 | -4.0% | 36.1% | 45 | 29 | 4.67 | +40.1% | 45 | 0.82 |
|
JANTS
|
15.20 | 10.6B | — | 1.49 | 21.82 | 2.2% | 38.9% | 43 | 24 | 13.74 | -6.1% | 70 | 0.23 |
|
FMIZP
|
281.00 | 4.0B | 42.11 | 6.20 | 26.88 | 12.9% | 43.9% | 41 | 23 | 145.15 | -36.3% | 96 | 0.02 |
|
BFREN
|
124.70 | 15.3B | 100.00 | 26.55 | 48.50 | 21.7% | 43.4% | 35 | 23 | 32.92 | -55.2% | 85 | 0.46 |
|
BALAT
|
72.10 | 2.0B | 71.12 | 31.71 | 121.64 | -26.3% | 46.0% | 26 | 9 | 22.14 | -47.8% | 79 | 0.00 |
|
DITAS
|
20.70 | 3.5B | — | 3.08 | 19.39 | -12.6% | 43.9% | 26 | 24 | 15.44 | -12.9% | 37 | 0.32 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.